EP Patent

EP0162705B1 — Injection of nicardipine hydrochloride and production thereof

Assigned to Yamanouchi Pharmaceutical Co Ltd · Expires 1991-05-29 · 35y expired

What this patent protects

This invention provides an injection of nicardipine hydrochloride comprising an aqueous nicardipine hydrochloride solution containing 2 to 7 w/v % of polyhydric alcohol and having a pH of 2.5 to 5.5.

USPTO Abstract

This invention provides an injection of nicardipine hydrochloride comprising an aqueous nicardipine hydrochloride solution containing 2 to 7 w/v % of polyhydric alcohol and having a pH of 2.5 to 5.5.

Drugs covered by this patent

nicardipine-hydrochloride (NICARDIPINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP0162705B1
Jurisdiction: EP
Classification: —
Expires: 1991-05-29
Drug substance claim: No
Drug product claim: No
Assignee: Yamanouchi Pharmaceutical Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.